| GMAB | 4.63% | 32.73 | -1.76% | 1,591,311 | |
| UTHR | 4.52% | 458.50 | +1.15% | 115,234 | |
| ALNY | 4.27% | 459.95 | +1.76% | 108,129 | |
| ARGX | 4.21% | 795.51 | +0.96% | 60,785 | |
| ONC | 4.05% | 343.16 | -0.40% | 136,053 | |
| VCYT | 3.92% | 34.69 | -3.75% | 1,257,535 | |
| INCY | 3.74% | 86.95 | -0.32% | 496,487 | |
| SRPT | 3.68% | 23.28 | +0.06% | 1,874,193 | |
| KRYS | 3.65% | 182.17 | +0.88% | 229,831 | |
| CORT | 3.62% | 89.87 | +0.02% | 473,763 |
First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund is an exchange traded fund launched and managed by First Trust Advisors LP. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE Arca Biotechnology Index, by using full replication technique. First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund was formed on June 19, 2006 and is domiciled in the United States.